Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CMPX
CMPX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMPX News
Oncolytics Biotech Appoints New Executives to Accelerate Cancer Treatment Progress
Jan 14 2026
Globenewswire
Monte Rosa Therapeutics Shares Surge 45.2% After Phase 1 Data Release
Jan 07 2026
Benzinga
Compass Therapeutics Initiates Coverage with $1.46B Peak Sales Potential for Tovecimig
Jan 05 2026
Benzinga
Compass Therapeutics Appoints New Executives, Stock Rises 6.19%
Jan 05 2026
NASDAQ.COM
Reasons to Consider Compass Therapeutics, Inc. (CMPX) as a Strong Momentum Stock Investment
Dec 08 2025
NASDAQ.COM
Wednesday's Key Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy's, and More
Dec 03 2025
Yahoo Finance
Linde Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Wednesday
Dec 03 2025
Benzinga
Cantor Fitzgerald Begins Coverage of Compass Therapeutics with an Overweight Rating
Dec 03 2025
Yahoo Finance
Analysts Show High Confidence in Compass Therapeutics (CMPX) Following Progress with CTX-10726
Dec 01 2025
Yahoo Finance
Zacks.com Spotlights Orla Mining, FIGS, and Compass Therapeutics
Nov 24 2025
NASDAQ.COM
"Don't Miss These Top 3 Breakout Stocks for Active Traders in 2025!"
Nov 20 2025
NASDAQ.COM
Compass Therapeutics, Inc. (CMPX) Shares Insights at Morgan Stanley's 23rd Annual Global Healthcare Conference Transcript
Sep 10 2025
Newsfilter
Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
Aug 13 2025
Newsfilter
Compass Therapeutics rises after pipeline updates
Aug 11 2025
SeekingAlpha
Compass Therapeutics Posts Wider Q2 Loss
Aug 11 2025
NASDAQ.COM
Raymond James Reinstates Outperform on Compass Therapeutics, Announces $9 Price Target
Jul 01 2025
Benzinga
Show More News
